By health condition
By demographic
Each summary is provided by the external research team. The views expressed may not reflect those of the NIHR BioResource.
We’ve also created a few study collections:
Studies 316-324 of 422
Assessment of efficacy and adverse events following SARS-CoV-2 cohort of subjects previously infected with COVID-19
Speciality areaInfection, COVID
Study typeParticipant re-contact
Researcher typeAcademic
Research leadDr James Thaventhiran
Our Future Health (Previously Accelerating Detection of Disease)
Speciality areaPublic Health and Prevention, Cross-cutting
Research leadDr Andrew Roddam
Neurological complications of COVID-19 (NeuroCOVID)_CONTROLS
Speciality areaInfection, Neurological Disorders, COVID
Study typeSamples and data
Research leadProfessor David Menon
Diagnostic sequence analysis in patients with renal diseases
Speciality areaLiver, Genomics and Rare Diseases
Study typeData only
Research leadAli Gharavi
Investigation of Omics in Chronic Widespread Pain
Speciality areaGenomics and Rare Diseases, Anaesthesia, Perioperative Medicine and Pain Management
Research leadFrances Williams
Post-COVID-19 surveillance: To establish T cell assays for assessing T cell responses and identify individual and immunological factors that account for different disease outcomes
Research leadDr Nyarie Sithole
Healthcare Worker T Cell Recall
Genome medicine for platelet disorders (access to 'Chromoscope' data platform)
Speciality areaGenomics and Rare Diseases, Haematology
Research leadDr Hugo Ferreira Ponte
Neurological complications of COVID-19 (NeuroCOVID)
